IPH (IPH) AGM 2024 summary
Event summary combining transcript, slides, and related documents.
AGM 2024 summary
25 Jun, 2026Opening remarks and agenda
Meeting opened with acknowledgment of traditional custodians and introduction of board, executives, and auditors.
Notice of meeting and annual report made available; agenda followed as per notice.
Shareholders invited to ask questions during relevant agenda items and at the end.
Financial performance review
Revenue increased 22.9% to AUD 609.9 million; underlying EBITDA up 15% to AUD 195.5 million.
Underlying net profit after tax rose 13.5% to AUD 112.4 million; EPS up 5.6% to AUD 0.46.
Dividends per share grew 6.1% to AUD 0.35, with full-year dividends increasing annually since 2014.
Canadian acquisitions contributed significantly to revenue and earnings growth.
Asia saw a 6% decline in like-for-like earnings, but signs of recovery are emerging.
Board and executive committee updates
Board renewal continued with Robin Low's retirement and David Willis's appointment.
Board engaged with shareholders on remuneration and capital management.
Chairman Peter Warne offered himself for reelection, highlighting his experience.
Latest events from IPH
- EBITDA and NPAT rose 15% and 14%, with leverage at 1.9x and strong Canadian integration.IPH
H2 202428 May 2026 - Revenue up 16.5% to AUD 710.3m, with strong cash flow, higher dividends, and cost savings ahead.IPH
H2 202528 May 2026 - Underlying NPAT up 20% to $61.0m, revenue up 25.5%, and net debt down 16%.IPH
H1 202528 May 2026 - NPAT up 10.5% to $41.2m, revenue up 6.5%, and 19.0c dividend with buy-back in March 2026.IPH
H1 202628 May 2026 - Profit growth, board renewal, and CEO succession amid U.S. and Canadian market challenges.IPH
AGM 202520 Nov 2025 - IPH acquires Bereskin & Parr, expanding in Canada and launching a major equity raise.IPH
Investor Presentation13 Jun 2025 - Market-leading IPH Limited drives growth through innovation, efficiency, and global expansion.IPH
Company Presentation6 Jun 2025